Revisiting Cell Screening To Find New Cancer Drug Combos
Executive Summary
Evidence is slowly building of the potential of high-throughput screening of individual patient tumors to test their sensitivity and response to hundreds of combinations of cancer drugs, first in leukemia and hopefully for treating other cancers.